Candida kruzei-related systemic infections are increasing in frequency, particularly in patients receiving prophylaxis with antifungal triazoles. A Caucasian male with newly diagnosed acute myeloid leukaemia (AML M1) developed severe and persistent fever associated with a micropustular eruption scattered over the trunk and limbs during induction chemotherapy. Blood cultures grew Candida kruzei, and biopsies of the skin lesions revealed a candida vasculitis. He responded to high doses of liposomal amphotericin B and was discharged well from hospital. Keywords: systemic candidiasis; candida vasculitis; Candida kruzei; triazoles; leukaemia; bone marrow transplantation
A 48-year-old man presented with increasing dyspnoea and bruising. Full blood count revealed circulating blasts and he was admitted to hospital for further investigation and treatment. He was neutropenic, with a total WBC of 1.9 (5% neutrophils) and his bone marrow aspirate was consistent with a diagnosis of AML M1, with 87% blasts. Cytogenetic analysis revealed a complex hyperdiploid clone with monosomy 5. He commenced induction chemotherapy (cytosine arabinoside 2 g/m 2 i.v. for 5 days, etoposide 100 mg/m 2 i.v. for 5 days and idarubicin 5 mg/m 2 i.v. for 5 days).
On day ϩ2 (day 2) following completion of chemotherapy he became pyrexial and was commenced on tazosin, gentamicin, teicoplanin and fluconazole. The following day he was afebrile and remained so for the next week. Cultures at this time were negative.
On day 10 he again became pyrexial and blood cultures grew Candida kruzei, sensitive to amphotericin B and resistant to fluconazole. His central line was removed and he commenced amphotericin B at a dose of 1 mg/kg/day, and ciprofloxacin was added to the antibiotic regimen. He remained febrile, and 2 days later became very unwell with a generalised micropustular purpuric eruption scattered over scalp, trunk and limbs, and cough and dyspnoea. He had deteriorating renal function and so was changed to liposomal amphotericin B, 5 mg/kg/day, which he continued until his discharge 6 weeks later.
He was hypoxic on air with a saturation of 83% and had widespread inspiratory and expiratory crepitations on auscultation of the chest. High-dose septrin and clarithromycin were added to the antibiotic regimen. Chest X-ray showed no abnormality. Biopsy of the skin rash showed a leucocytoclastic-like vasculitis associated with the presence of budding yeasts within the vessels and surrounding tissue, consistent with candida infection.
He remained pyrexial over the next 9 days despite further line and antibiotic changes, and repeated blood cultures were negative. He had a transient rise in liver enzymes but liver ultrasound and abdominal CT scan were normal. His white cell count recovered with GM-CSF stimulation at day 21 and his pyrexia settled. He was discharged home 6 weeks after admission taking itraconazole 200 mg twice a day, which provided adequate blood levels (0.63 mg/l). His bone marrow aspirate on discharge showed remission, and the rash resolved completely.
He subsequently underwent a peripheral blood stem cell autograft, for which he was conditioned with high-dose melphalan 200 mg/m 2 , and during which he experienced no recrudescence of his earlier problems. He continued with the oral itraconazole throughout this procedure. It was discontinued 4 weeks later, following recovery of his white blood cell count and in the absence of any features suggestive of the earlier Candida kruzei infection.
He continues completely well, 8 months later.
Discussion
Haematogenous spread of infections such as Candida kruzei appears to be increasing in frequency, particularly in patients receiving prophylaxis with antifungal triazoles. 1 Many transplant units routinely use such drugs as prophylaxis or as first-line treatment for oral candidiasis. Disseminated candida infections with skin involvement have been described in intravenous drug abusers: in a group of seven men known to be heroin addicts, candidiasis was associated with skin lesions confined to the scalp and other hair-bearing areas, in association with osteomyelitis and endopthalmitis. 2 Our patient did not have this full clinical picture, his only manifestations being fever and rash in a similar distribution to that seen in the drug abusers. Skin rashes due to Candida albicans 3 and Candida guillermondii 4 have previously been described in immunosuppressed patients undergoing myelosuppressive chemotherapy and BMT.
Candida kruzei is typically resistant to fluconazole. Our patient initially received amphotericin B, but due to deteriorating renal function he was changed to a liposomal preparation. Studies in neutropenic mice infected with Candida kruzeii suggest that liposomal preparations are more effective in reducing fungal burden but that there is no difference in overall survival. 5 This case illustrates the importance of skin biopsy as a diagnostic tool in the septic neutropenic patient. Emergence of more resistant fungal strains associated with the use of prophylactic antifungal triazoles is of great significance particularly in bone marrow transplantation and haematooncology units, and use of prophylactic antifungal agents such as liposomal amphotericin in patients who have received prior therapy with triazoles and are about to embark upon a bone marrow transplant procedure should be considered.
